{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:45:31Z","timestamp":1793317531462,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ajoc.2024.102098","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T01:22:21Z","timestamp":1720228941000},"page":"102098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Anti-TRPM1 autoantibody-positive unilateral melanoma associated retinopathy (MAR) triggered by immunotherapy recapitulates functional and structural details of TRPM1-associated congenital stationary night blindness"],"prefix":"10.1016","volume":"36","author":[{"given":"Devin C.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Sumaroka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4742-6557","authenticated-orcid":false,"given":"Joshua A.","family":"Paulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara C.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene J.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin C.","family":"O'Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma C.","family":"Bedoukian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0636-4898","authenticated-orcid":false,"given":"Grazyna","family":"Adamus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2018-0905","authenticated-orcid":false,"given":"Artur V.","family":"Cideciyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas S.","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2024.102098_bib1","first-page":"477","article-title":"'On' response defect in paraneoplastic night blindness with cutaneous malignant melanoma","volume":"33","author":"Alexander","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2024.102098_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0952523800003175","article-title":"Recoverin immunoreactivity in mammalian cone bipolar cells","volume":"10","author":"Milam","year":"1993","journal-title":"Vis Neurosci"},{"key":"10.1016\/j.ajoc.2024.102098_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.autrev.2009.01.002","article-title":"Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy","volume":"8","author":"Adamus","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajoc.2024.102098_bib4","series-title":"Uveitis Update: Proceedings of the First International Symposium on Uveitis","first-page":"407","article-title":"Acute Vogt-Koyanagi-Harada-like syndrome occurring in a patient with metastatic cutaneous melanoma","author":"Gass","year":"1984"},{"key":"10.1016\/j.ajoc.2024.102098_bib5","first-page":"18","article-title":"Vogt\u2013Koyanagi\u2013Harada-like uveitis followed by melanoma-associated retinopathy with foveal chorioretinal atrophy and choroidal neoveascularizatio in a patient with metastatic cutaneous melanoma","volume":"17","author":"Ng","year":"2023"},{"key":"10.1016\/j.ajoc.2024.102098_bib6","first-page":"91","article-title":"Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy","volume":"34","author":"Milam","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2024.102098_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0002-9394(14)76622-X","article-title":"Paraneoplastic night blindness with malignant melanoma","volume":"106","author":"Berson","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00041327-200109000-00004","article-title":"Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases","volume":"21","author":"Keltner","year":"2001","journal-title":"J Neuro Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib9","first-page":"787","article-title":"Functional abnormalities in vincristine-induced night blindness","volume":"25","author":"Ripps","year":"1984","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.ajoc.2024.102098_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231750","article-title":"Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy","volume":"15","author":"Varin","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ajoc.2024.102098_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/OPTH.S55124","article-title":"Choroidal atrophy in a patient with paraneoplastic retinopathy and anti-TRPM1 antibody","volume":"8","author":"Ueno","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib12","first-page":"2410","article-title":"Clinical course of paraneoplastic retinopathy with anti-TRPM1 autoantibody in Japanese cohort","volume":"39","author":"Ueno","year":"2019"},{"key":"10.1016\/j.ajoc.2024.102098_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/6607441","article-title":"Clinical findings of melanoma-associated retinopathy with anti-TRPM1 antibody","volume":"2021","author":"Shinohara","year":"2021","journal-title":"Case Reports in Ophthalmological Medicine"},{"key":"10.1016\/j.ajoc.2024.102098_bib14","first-page":"262","article-title":"Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo","volume":"41","author":"Lei","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2024.102098_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10633-007-9074-9","article-title":"Cancer-associated retinopathy (CAR) with electronegative ERG: a case report","volume":"116","author":"Goetgebuer","year":"2008","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10633-012-9327-0","article-title":"Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer: a differential diagnostic challenge in a patient with unexplained visual loss","volume":"125","author":"Carboni","year":"2012","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10633-014-9470-x","article-title":"Case of paraneoplastic retinopathy with retinal ON-bipolar cell dysfunction and subsequent resolution of ERGs","volume":"130","author":"Ueno","year":"2015","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib18","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1001\/archophthalmol.2009.311","article-title":"Melanoma-associated retinopathy: a paraneoplastic autoimmune complication","volume":"127","author":"Lu","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019911","article-title":"Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction","volume":"6","author":"Kondo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ajoc.2024.102098_bib20","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1523\/JNEUROSCI.6007-10.2011","article-title":"Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells","volume":"31","author":"Dhingra","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajoc.2024.102098_bib21","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1167\/iovs.17-21443","article-title":"Autoantibodies in melanoma-associated retinopathy recognize an epitope conserved between TRPM1 and TRPM3","volume":"58","author":"Duvoisin","year":"2017","journal-title":"Investigative Opthalmology & Visual Science"},{"key":"10.1016\/j.ajoc.2024.102098_bib22","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1167\/iovs.19-26775","article-title":"TRPM1 autoantibodies in melanoma patients without self-reported visual symptoms","volume":"60","author":"Duvoisin","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2024.102098_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069506","article-title":"Serum TRPM1 autoantibodies from melanoma associated retinopathy patients enter retinal ON-bipolar cells and attenuate the electroretinogram in mice","volume":"8","author":"Xiong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajoc.2024.102098_bib24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/bies.200900198","article-title":"TRPM1: the endpoint of the mGluR6 signal transduction cascade in retinal ON-bipolar cells","volume":"32","author":"Morgans","year":"2010","journal-title":"Bioessays"},{"key":"10.1016\/j.ajoc.2024.102098_bib25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1073\/pnas.0912730107","article-title":"TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade","volume":"107","author":"Koike","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajoc.2024.102098_bib26","doi-asserted-by":"crossref","DOI":"10.1017\/S0952523817000360","article-title":"Differential epitope masking reveals synapse-specific complexes of TRPM1","volume":"35","author":"Agosto","year":"2018","journal-title":"Vis Neurosci"},{"key":"10.1016\/j.ajoc.2024.102098_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101418","article-title":"The mGluR6 ligand-binding domain, but not the C-terminal domain, is required for synaptic localization in retinal ON-bipolar cells","volume":"297","author":"Agosto","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajoc.2024.102098_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ceca.2010.08.004","article-title":"TRPM1: a vertebrate TRP channel responsible for retinal ON bipolar function","volume":"48","author":"Koike","year":"2010","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ajoc.2024.102098_bib29","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ajhg.2009.10.013","article-title":"TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness","volume":"85","author":"Audo","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajoc.2024.102098_bib30","first-page":"288","article-title":"Ocular and orbital side-effects of checkpoint inhibitors","volume":"28","author":"Antoun","year":"2016","journal-title":"a review article"},{"key":"10.1016\/j.ajoc.2024.102098_bib31","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/IAE.0000000000002181","article-title":"Checkpoint inhibitor immune therapy: systemic indications and ophthalmic side effects","volume":"38","author":"Dalvin","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.ajoc.2024.102098_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","article-title":"ISCEV Standard for full-field clinical electroretinography (2022 update)","volume":"144","author":"Robson","year":"2022","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib33","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/S0161-6420(86)33522-X","article-title":"Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa","volume":"93","author":"Jacobson","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2024.102098_bib34","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archopht.1995.01100070024015","article-title":"Cutaneous melanoma-associated retinopathy with retinal periphlebitis","volume":"113","author":"Remulla","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib35","first-page":"211","article-title":"[Melanoma-associated retinopathy with unknown primary site in a Japanese woman]","volume":"110","author":"Murayama","year":"2006","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.ajoc.2024.102098_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10633-011-9277-y","article-title":"Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction","volume":"123","author":"Anastasakis","year":"2011","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib37","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/bjo.2009.163501","article-title":"Retinal imaging using commercial broadband optical coherence tomography","volume":"94","author":"Tanna","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib38","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1364\/BOE.10.002918","article-title":"Improving visible light OCT of the human retina with rapid spectral shaping and axial tracking","volume":"10","author":"Zhang","year":"2019","journal-title":"Biomed Opt Express"},{"key":"10.1016\/j.ajoc.2024.102098_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev-vision-030320-041255","article-title":"Cellular-scale imaging of transparent retinal structures and processes using adaptive optics optical coherence tomography","volume":"6","author":"Miller","year":"2020","journal-title":"Annual Review of Vision Science"},{"key":"10.1016\/j.ajoc.2024.102098_bib40","article-title":"In vivo morphometry of inner plexiform layer (IPL) stratification in the human retina with visible light optical coherence tomography","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.ajoc.2024.102098_bib41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/iovs.63.1.18","article-title":"In vivo sublayer analysis of human retinal inner plexiform layer obtained by visible-light optical coherence tomography","volume":"63","author":"Ghassabi","year":"2022","journal-title":"Investigative Opthalmology & Visual Science"},{"key":"10.1016\/j.ajoc.2024.102098_bib42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cne.10636","article-title":"Differential distribution and developmental expression of synaptic vesicle protein 2 isoforms in the mouse retina","volume":"460","author":"Wang","year":"2003","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.ajoc.2024.102098_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.5.3.10","article-title":"Selective automated perimetry under photopic, mesopic, and scotopic conditions: detection mechanisms and testing strategies","volume":"5","author":"Simunovic","year":"2016","journal-title":"Translational Vision Science & Technology"},{"key":"10.1016\/j.ajoc.2024.102098_bib44","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/08164622.2021.2023477","article-title":"Scotopic microperimetry: evolution, applications and future directions","volume":"105","author":"Taylor","year":"2022","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.ajoc.2024.102098_bib45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/0974-620X.159273","article-title":"Melanoma associated retinopathy: a new dimension using adaptive optics","volume":"8","author":"Dabir","year":"2015","journal-title":"Oman J Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib46","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/IAE.0b013e3182398107","article-title":"Hyperautofluorescent ring in autoimmune retinopathy","volume":"32","author":"Lima","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.ajoc.2024.102098_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10633-017-9587-9","article-title":"Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy","volume":"134","author":"Chen","year":"2017","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5935\/0004-2749.20230006","article-title":"A slow-release dexamethasone implant for cancer-associated retinopathy","volume":"86","author":"Chaves","year":"2023","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib49","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1097\/IAE.0000000000001666","article-title":"Localized bilateral juxtafoveal photoreceptor loss in poems: a new association","volume":"37","author":"Hwang","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.ajoc.2024.102098_bib50","unstructured":"Miller CG, Brucker AJ, Perry LM, et al. Outer Retinopathy and Microangiopathy in Acute Myelogenous Leukemia. vol. 9900;10.1097\/ICB.0000000000001294."},{"key":"10.1016\/j.ajoc.2024.102098_bib51","article-title":"Predictive value of genetic testing for inherited retinal diseases in patients with suspected atypical autoimmune retinopathy","volume":"15","author":"Stanwyck","year":"2019","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.ajoc.2024.102098_bib52","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/s41433-021-01676-x","article-title":"Paraneoplastic ocular syndrome: a pandora's box of underlying malignancies","volume":"36","author":"Sarkar","year":"2022","journal-title":"Eye"},{"key":"10.1016\/j.ajoc.2024.102098_bib53","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/bjophthalmol-2014-305897","article-title":"Retinal degeneration in autoimmune polyglandular syndrome type 1: a case series","volume":"99","author":"Bourgault","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajoc.2022.101266","article-title":"Clinical, histological and genetic findings in a donor with a clinical history of type 1 Autoimmune Polyendocrinopathy Syndrome","volume":"25","author":"Culp","year":"2022","journal-title":"American Journal of Ophthalmology Case Reports"},{"key":"10.1016\/j.ajoc.2024.102098_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-021-00751-5","article-title":"AUY922 induces retinal toxicity through attenuating TRPM1","volume":"28","author":"Shen","year":"2021","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.ajoc.2024.102098_bib56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/ICB.0000000000000604","article-title":"Acute exudative paraneoplastic polymorphous vitelliform maculopathy during vemurafenib and pembrolizumab treatment for metastatic melanoma","volume":"13","author":"Sandhu","year":"2019","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.ajoc.2024.102098_bib57","first-page":"227","volume":"vol. 42","author":"Essilfie","year":"2022"},{"key":"10.1016\/j.ajoc.2024.102098_bib58","first-page":"2368","article-title":"Comparison of primary and secondary forms of multiple evanescent white dot","volume":"42","author":"Serrar","year":"2022","journal-title":"SYNDROME"},{"key":"10.1016\/j.ajoc.2024.102098_bib59","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1017\/S0952523805225038","article-title":"Photoreceptor calcium channels: insight from night blindness","volume":"22","author":"Morgans","year":"2005","journal-title":"Vis Neurosci"},{"key":"10.1016\/j.ajoc.2024.102098_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108770","article-title":"Broad locations of antigenic regions for anti-TRPM1 autoantibodies in paraneoplastic retinopathy with retinal ON bipolar cell dysfunction","volume":"212","author":"Gyoten","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajoc.2024.102098_bib61","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.ophtha.2013.07.037","article-title":"Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing","volume":"120","author":"Dalal","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2024.102098_bib62","first-page":"851","article-title":"Long-term follow-up of retinal function and structure in TRPM1-associated complete congenital stationary night blindness","volume":"25","author":"Al-Hujaili","year":"2019","journal-title":"Mol Vis"},{"key":"10.1016\/j.ajoc.2024.102098_bib63","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s00417-016-3346-6","article-title":"Congenital stationary night blindness with hypoplastic discs, negative electroretinogram and thinning of the inner nuclear layer","volume":"254","author":"Al Oreany","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081507","article-title":"Degeneration of retinal on bipolar cells induced by serum including autoantibody against TRPM1 in mouse model of paraneoplastic retinopathy","volume":"8","author":"Ueno","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajoc.2024.102098_bib65","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajoc.2024.102098_bib66","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/annonc\/mdw141","article-title":"Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies","volume":"27","author":"Naidoo","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ajoc.2024.102098_bib67","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.revmed.2017.01.004","article-title":"Opportunistic autoimmunity secondary to cancer immunotherapy (OASI): an emerging challenge","volume":"38","author":"Kostine","year":"2017","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.ajoc.2024.102098_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002119","article-title":"Ocular adverse events in PD-1 and PD-L1 inhibitors","volume":"9","author":"Young","year":"2021","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"10.1016\/j.ajoc.2024.102098_bib69","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2021-000889","article-title":"Autoimmune retinopathy with associated anti-retinal antibodies as a potential immune-related adverse event associated with immunotherapy in patients with advanced cutaneous melanoma: case series and systematic review","volume":"7","author":"Heng","year":"2022","journal-title":"BMJ Open Ophthalmology"},{"key":"10.1016\/j.ajoc.2024.102098_bib70","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/IAE.0000000000000242","article-title":"Retinal toxicities of cancer therapy drugs: biologics, small molecule inhibitors, and chemotherapies","volume":"34","author":"Liu","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.ajoc.2024.102098_bib71","doi-asserted-by":"crossref","DOI":"10.1186\/s12348-023-00338-1","article-title":"Relation between ocular paraneoplastic syndromes and Immune Checkpoint Inhibitors (ICI): review of literature","volume":"13","author":"Casselman","year":"2023","journal-title":"Journal of Ophthalmic Inflammation and Infection"},{"key":"10.1016\/j.ajoc.2024.102098_bib72","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s41433-019-0473-4","article-title":"Metastatic melanoma and immunotherapy-related uveitis: an incidence in Northern Ireland","volume":"33","author":"Dolaghan","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.ajoc.2024.102098_bib73","doi-asserted-by":"crossref","DOI":"10.1177\/1758835921992989","article-title":"Ocular adverse events associated with immune checkpoint inhibitors: a novel multidisciplinary management algorithm","volume":"13","author":"Shahzad","year":"2021","journal-title":"Therapeutic Advances in Medical Oncology"},{"key":"10.1016\/j.ajoc.2024.102098_bib74","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/ICB.0000000000000882","article-title":"Choroidal neovascularization and chorioretinal atrophy in a patient with melanoma-associated retinopathy after ipilimumab\/nivolumab combination therapy","volume":"15","author":"Elwood","year":"2021","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.ajoc.2024.102098_bib75","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ophtha.2019.01.031","article-title":"Ophthalmic immune-related adverse events of immunotherapy: a single-site case series","volume":"126","author":"Kim","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2024.102098_bib76","article-title":"Frequent subclinical macular changes in combined BRAF\/MEKinhibition with high-dose hydroxychloroquine as treatment for advanced BRAF mutant melanoma: preliminary results from a phase I\/II clinical treatment trial","author":"Nti","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.ajoc.2024.102098_bib77","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/ICB.0000000000000675","article-title":"Immune retinopathy associated with nivolumab administration for metastatic non-small cell lung cancer","volume":"14","author":"Reddy","year":"2020","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.ajoc.2024.102098_bib78","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.jcjo.2014.04.007","article-title":"Unilateral manifestation of autoimmune retinopathy","volume":"49","author":"Almeida","year":"2014","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib79","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0036933015598124","article-title":"Unilateral cancer-associated retinopathy: a case report","volume":"61","author":"Javaid","year":"2016","journal-title":"Scott Med J"},{"key":"10.1016\/j.ajoc.2024.102098_bib80","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10633-017-9605-y","article-title":"Unilateral cancer-associated retinopathy: diagnosis, serology and treatment","volume":"135","author":"Roels","year":"2017","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib81","first-page":"866","article-title":"Unilateral manifestation of melanoma-associated retinopathy","volume":"120","author":"Janaky","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib82","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1136\/bjo.2007.116681","article-title":"Unilateral diffuse uveal melanocytic proliferation (DUMP)","volume":"91","author":"Reddy","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102098_bib83","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/ICB.0000000000000519","article-title":"Unilateral diffuse uveal melanocytic proliferation","volume":"12","author":"Spaide","year":"2018","journal-title":"Retin Cases Brief Rep"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624001087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624001087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T04:38:15Z","timestamp":1737693495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993624001087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":83,"alternative-id":["S2451993624001087"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102098","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-TRPM1 autoantibody-positive unilateral melanoma associated retinopathy (MAR) triggered by immunotherapy recapitulates functional and structural details of TRPM1-associated congenital stationary night blindness","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102098"}}